Literature DB >> 22316442

The emerging threat of untreatable gonococcal infection.

Gail A Bolan1, P Frederick Sparling, Judith N Wasserheit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22316442     DOI: 10.1056/NEJMp1112456

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  102 in total

1.  A doctor's dilemma: choices amidst change.

Authors:  P Frederick Sparling
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

2.  Phosphoethanolamine decoration of Neisseria gonorrhoeae lipid A plays a dual immunostimulatory and protective role during experimental genital tract infection.

Authors:  Mathanraj Packiam; Roshan D Yedery; Afrin A Begum; Russell W Carlson; Jhuma Ganguly; Gregory D Sempowski; Melissa S Ventevogel; William M Shafer; Ann E Jerse
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 3.  Preparing for an era of untreatable gonorrhea.

Authors:  Lindley A Barbee
Journal:  Curr Opin Infect Dis       Date:  2014-06       Impact factor: 4.915

Review 4.  Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Lao-Tzu Allan-Blitz; Xiaoyan Wang; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2017-05       Impact factor: 2.830

5.  Properly folded and functional PorB from Neisseria gonorrhoeae inhibits dendritic cell stimulation of CD4+ T cell proliferation.

Authors:  Weiyan Zhu; Joshua Tomberg; Kayla J Knilans; James E Anderson; Karen P McKinnon; Gregory D Sempowski; Robert A Nicholas; Joseph A Duncan
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

6.  Gentamicin as an alternative treatment for gonorrhoea.

Authors:  Robert D Kirkcaldy; Kimberly A Workowski
Journal:  Lancet       Date:  2019-05-02       Impact factor: 79.321

7.  Selective Inhibition of Neisseria gonorrhoeae by a Dithiazoline in Mixed Infections with Lactobacillus gasseri.

Authors:  Jonathan D Lenz; Kristina A Shirk; Adrienne Jolicoeur; Joseph P Dillard
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

8.  Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12.

Authors:  Yingru Liu; Nejat K Egilmez; Michael W Russell
Journal:  J Infect Dis       Date:  2013-09-18       Impact factor: 5.226

9.  A Moonlighting Enolase from Lactobacillus gasseri does not Require Enzymatic Activity to Inhibit Neisseria gonorrhoeae Adherence to Epithelial Cells.

Authors:  Rachel R Spurbeck; Paul T Harris; Kannan Raghunathan; Dennis N Arvidson; Cindy Grove Arvidson
Journal:  Probiotics Antimicrob Proteins       Date:  2015-09       Impact factor: 4.609

10.  Modernizing operations to improve efficiency and refine the role and mission of sexually transmitted infection clinics.

Authors:  Julia C Dombrowski; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2013-01       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.